Skip to content
CancerIndex

Publication

Patient-reported symptom monitoring in patients with lung cancer (SYMPRO-Lung trial): long-term, post-hoc survival results of a multicentre, stepped-wedged, cluster-randomised clinical trial.

Marloes J Hassing, Nicole E Billingy, Corina J G van den Hurk, Michel M van den Heuvel, Cornelia A Verberkt, Annemarie Becker-Commissaris, Iris Walraven, SYMPRO-Lung consortium

The Lancet. OncologyOct 1, 2026PMID 42727592doi:10.1016/S1470-2045(26)00305-0 Journal ArticleMulticenter StudyRandomized Controlled TrialpubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Patient-reported outcome (PRO) symptom monitoring has been shown to improve overall survival. Yet, available evidence largely derives from resource-intensive studies limited to patients with advanced cancer. We aimed to assess the effect of PRO symptom monitoring on overall and…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.